Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
The second AACR Childhood Cancer Predisposition Workshop gathered experts from around the world to refine surveillance strategies, expanding recommendations...
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and...
New clinical trials are exploring an array of CAR T-cell approaches for children with cancers of the brain and...
The summer, espionage-themed edition of From the Bench highlights in vivo cancer therapies that spring into action inside the...
Advances in cardio-oncology are redefining cancer care, shaping safer treatments to protecting patients’ hearts.
New AI-driven models unveiled at the AACR Annual Meeting 2025 could revolutionize how we diagnose sarcomas in children.
During his Pezcoller Foundation-AACR Award lecture, Douglas Hanahan, PhD, FAACR, highlighted ways to overcome systemic immunosuppression.
A single-cell atlas helped clarify diverse forms of acute myeloid leukemia, with potential implications for improving diagnostic, prognostic, and...
The New Drugs on the Horizon sessions at AACR Annual Meeting 2025 unveiled 12 novel cancer therapeutics and discussed...